首页|c-Myc调控葡萄糖转运蛋白4激活酪氨酸激酶/信号转导与转录激活因子促进三阴性乳腺癌机制研究

c-Myc调控葡萄糖转运蛋白4激活酪氨酸激酶/信号转导与转录激活因子促进三阴性乳腺癌机制研究

扫码查看
目的 探讨c-Myc调控葡萄糖转运蛋白4(GLUT4)激活酪氨酸激酶(JAK)/信号转导与转录激活因子(STAT)信号通路促进三阴性乳腺癌(TNBC)进展机制.方法 通过生信分析GLUT4、c-Myc关联性及GLUT4与乳腺癌临床病理特征间关系.收集三阴性乳腺癌患者临床样本,免疫组织化学检测GLUT4和c-Myc表达水平.构建敲除c-Myc的MDA-MB-231细胞株,通过实时定量反转录聚合酶链反应(RT-qPCR)及蛋白质印迹法(Western blot)检测GLUT4表达水平.构建敲除GLUT4和同时敲除GLUT4及c-Myc的MDA-MB-231细胞株,细胞计数试剂盒(CCK-8)检测增殖,流式细胞仪检测凋亡,Transwell检测迁移和侵袭.Western blot进一步分析c-Myc调控GLUT4对JAK/STAT的影响.正态分布计量资料比较采用独立样本t检验,多组资料组间比较采用方差分析.结果 生信分析结果显示,在乳腺癌中GLUT4明显下调(P<0.01)且与乳腺癌TNM分期、病理分级、PAM50分型等相关.免疫组织化学评分结果显示,c-Myc在TNBC癌组织中表达显著高于癌旁组织(7.233 比 4.567,t=4.551,P<0.01),而 GLUT4 显著低表达(4.800 比 7.933,t=5.702,P<0.01).在MDA-MB-231细胞中敲除c-Myc,RT-qPCR结果显示,c-Myc敲除组GLUT4表达量高于阴性对照组(2.486±0.273 比 1.070±0.140,F=55.005,P<0.01),Western blot 结果显示,c-Myc 敲除组 GLUT4 表达量高于阴性对照组(0.691±0.041 比 0.431±0.055,F=29.027,P<0.01).构建GLUT4低表达的MDA-MB-231细胞株,RT-qPCR结果显示,GLUT4沉默组表达量低于阴性对照组,差异有统计学意义(0.507±0.076/0.137±0.025/0.317±0.085 比 1.150±0.200,F=45.016,P<0.01).CCK-8结果显示,组细胞存活率高于阴性对照组(128.614±13.780比95.875±9.130,F=26.927,P<0.01),继续敲除c-Myc后细胞存活率低于阴性对照组(70.977±5.906比95.875± 9.130,F=26.927,P<0.01).流式细胞术结果显示,同时敲除GLUT4及c-Myc后细胞凋亡高于阴性对照组(12.170±1.283 比 3.263±0.691,F=102.946,P<0.01).Transwell 结果显示,敲除GLUT4后细胞迁移数高于阴性对照组[(237.333±14.364)个 比(156.667±10.693)个,F=91.074,P<0.01]、侵袭数高于阴性对照组[(257.000±9.539)个比(152.333±5.132)个,F=90.437,P<0.01],细胞迁移侵袭能力增强,而同时敲除c-Myc和GLUT4后细胞迁移数低于阴性对照组[(67.000±14.177)个 比(156.667±10.693)个,F=91.074,P<0.01]、侵袭数低于阴性对照组[(91.667±13.650)个比(152.333±5.132)个,F=90.437,P<0.01],细胞迁移侵袭能力减弱.Western blot 结果显示,敲除 GLUT4 后 c-Myc(0.814±0.060 比 0.447±0.028)、p-JAK2(0.629± 0.038 比 0.380±0.030)、p-STAT3(0.698±0.029 比 0.288±0.016)表达量均高于相应阴性对照组(F=17.541,P<0.01),而继续敲低c-Myc后,GLUT4表达量高于单纯敲低GLUT4组(0.618± 0.029 比 0.529±0.049,F=68.772,P<0.05),p-JAK2(0.510±0.033 比 0.629±0.038)、p-STAT3(0.410±0.050 比 0.698±0.029)表达量低于单纯敲低 GLUT4 组(F=68.772,P<0.01).结论 在三阴性乳腺癌中,c-Myc可抑制GLUT4表达并通过调控JAK/STAT信号通路影响肿瘤细胞的增殖侵袭和凋亡.
c-Myc regulates glucose transporters 4 to activate the janus kinase/signal transducer and activators of transcription to promote triple negative breast cancer
Objective To analyze the mechanism of c-Myc regulating glucose transporters 4(GLUT4)to activate janus kinase(JAK)/signal transducer and activators of transcription(STAT)to pro-mote the progression of triple negative breast cancer(TNBC),and to explore new therapeutic targets.Methods The relationship between GLUT4 and c-Myc and the clinicopathological features of breast cancer were analyzed by bioinformatics.Clinical samples of TNBC patients were collected,and the expression lev-els of GLUT4 and c-Myc were detected by immunohistochemistry.MDA-MB-231 cell line with c-Myc knockout was constructed,and the expression of GLUT4 was detected by real-time quantitative reverse tran-scriptase-polymerase chain reaction(RT-qPCR)and Western blotting.Cell counting kit-8(CCK-8)assay was used to detect proliferation,flow cytometry was used to detect apoptosis,and Transwell assay was used to detect migration and invasion.Western blotting was used to further analyze the effect of c-Myc regulating GLUT4 on JAK/STAT.The measurement data of the two groups of normal distribution data were compared using the independent sample t test,and the data between numerous groups were compared using analysis of variance.Results Bioinformatics analysis showed that GLUT4 was significantly down-regulated in breast cancer(P<0.01)and correlated with TNM stage,pathological grade and PAM50 subtype.Accord-ing to the immunohistochemical score,the expression levels of c-Myc in TNBC cancer tissues were signifi-cantly higher than paracancerous tissues(7.233 vs.4.567,t=4.551,P<0.01),while GLUT4 expres-sion was significantly lower(4.800 vs.7.933,t=5.702,P<0.01).When c-Myc was knocked out in MDA-MB-231 cells,RT-qPCR results showed that the expression of GLUT4 in c-Myc knockout group was higher than that in negative control group(2.486±0.273 vs.1.070±0.140,F=55.005,P<0.01).Western blotting results showed that the expression of GLUT4 in c-Myc knockout group was higher than that in negative control group(0.691±0.041 vs.0.431±0.055,F=29.027,P<0.01).MDA-MB-231 cell line with low GLUT4 expression was constructed,and RT-qPCR showed that there were significant differences in the GLUT4 expression between GLUT4 silencing group and negative control group(0.507±0.076/0.137±0.025/0.317±0.085 vs.1.150±0.200,F=45.016,P<0.01).CCK-8 results showed that the cell survival rate increased after GLUT4 knockdown(128.614±13.780 vs.95.875±9.130,F=26.927,P<0.01),and the cell survival rate was relatively reduced after further knocking out c-Myc(70.977± 5.906 vs.95.875±9.130,F=26.927,P<0.01).The results of flow cytometry showed that apoptosis was increased after knocking out GLUT4 and c-Myc simultaneously(12.170±1.283 vs.3.263±0.691,F=102.946,P<0.01).Transwell results showed that the number of migrating cells[(237.333±14.364)cells vs.(156.667±10.693)cells,F=91.074,P<0.01],and the number of invasive cells[(257.000± 9.539)cells vs.(152.333±5.132)cells,F=90.437,P<0.01]in GLUT4 knockdown group were signifi-cantly greater than those in the negative control group.After knocking out GLUT4 and c-Myc simultaneously,the number of migrating cells[(67.000±14.177)cells vs.(156.667±10.693)cells,F=91.074,P<0.01]and the number of invasive cells[(91.667±13.650)cells vs.(152.333±5.132)cells,F=90.437,P<0.01]were significantly less than those in the negative control group.Western blotting results showed that the expression of c-Myc(0.814±0.060 vs.0.447±0.028),p-JAK2(0.629±0.038 vs.0.380±0.030)and p-STAT3(0.698±0.029 vs.0.288±0.016)was up-regulated after GLUT4 knock-out(F=17.541,P<0.01).The GLUT4 expression was relatively increased after c-Myc knockdown(0.618±0.029 vs.0.529±0.049,F=68.772,P<0.05),and the expression of p-JAK2(0.510± 0.033 vs.0.629±0.038)and p-STAT3(0.410±0.050 vs.0.698±0.029)decreased(F=68.772,P<0.01).Conclusion c-Myc has the ability to suppress GLUT4 expression and control the JAK/STAT to limit the growth,invasion,and death of TNBC cells.

Triple negative breast cancerC-MycGlucose transporters 4Janus kinase/signal transducer and activators of transcription signaling pathway

张莹、范静婧、吴中语、马伟强、马斌林

展开 >

新疆医科大学附属肿瘤医院,新疆乳腺甲状腺肿瘤临床医学研究中心,乌鲁木齐 830011

三阴性乳腺癌 c-Myc 葡萄糖转运蛋白4 酪氨酸激酶/信号转导与转录激活因子信号通路

国家自然科学基金

82260549

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 8